OBJECTIVES: Management strategy for unbalanced complete atrioventricular septal defects (CASVSDs) includes single-ventricle (SV) palliation and primary or staged biventricular (BiV) repair. More recently, BiV conversion (BiVC) from SV palliation and staged BiV recruitment (BiVR) have also been advocated. This study assesses mid-term outcomes in patients with unbalanced CASVSDs according to management strategy.
INTRODUCTION
Unbalanced complete atrioventricular septal defects (CASVSDs) represent 10-15% of all atrioventricular septal defects [1, 2] . This defect is characterized by underdevelopment of one of the ventricles and varying degrees of malalignment of the common atrioventricular valve (AVV) over the hypoplastic ventricle and associated hypoplasia of the outflow valve related to decreased flow [1] . Management strategy includes single-ventricle (SV) palliation and primary or staged biventricular (BiV) repair [3] [4] [5] . More recently, BiV conversion (BiVC) from SV palliation has been advocated, particularly in patients with trisomy 21 and heterotaxy [6, 7] who tolerate SV palliation poorly [8] . Staged BiV recruitment (BiVR) has also been considered [9] . The objective of this study was to assess mid-term outcomes in patients in a tertiary care centre with unbalanced CASVSDs grouped according to management strategy.
MATERIAL AND METHODS

Patient population
A review of consecutive patients with unbalanced CASVSDs who were operated on at a tertiary care centre between January 2000 and February 2016 was performed with institutional review board approval and waiver of consent. Patients were divided into 3 groups: (i) those who had SV palliation; (ii) those who underwent primary or staged BiV repair and (iii) those who underwent BiVC from SV palliation or planned BiVR. Demographic, clinical, imaging and follow-up data were collected by reviewing clinical charts.
Definitions
Unbalanced CASVSD: was defined as a CASVSD with an AVV override of >60% over either ventricle (or) the presence of hypoplastic, non-apex-forming ventricles or, in the case of a right dominant CASVSD, a left ventricle with indexed volumes at least 2 SDs smaller than normal and those who were deemed unbalanced and underwent SV palliation at an outside institution. Types of repairs: SV palliation was defined as the traditional SV palliation towards a Fontan circulation. 'Primary BiV repair' was BiV repair as the primary surgery. 'Staged BiV repair' comprised of coarctation repair, aortopulmonary shunt, right ventricle to pulmonary artery shunt, pulmonary artery band or total repair of anomalous pulmonary venous return performed in the neonatal period, followed by BiV repair of unbalanced CASVSDs during infancy. 'BiV conversion' was defined as conversion to BiV circulation from prior SV palliation, which may occur at any of the 3 stages (following Stage I, superior cavopulmonary anastamosis or completion Fontan) of palliation. 'BiV recruitment' included modification of stages of palliation with a plan to recruit to a final BiV circulation; for example, restriction of the atrial septum and septation of the AVV at the time of the Stage I or superior cavopulmonary anastamosis. The techniques of BiVC and BiVR have been described previously [6, 7, 9, 10] .
Index surgery: was defined as the first palliation procedure for the SV group; BiV repair for the BiV group; and BiVC from SV palliation or first surgery for BiVR for the BiVC/BiVR group.
Mortality: was defined as death any time after the index surgery. Reintervention: included any unplanned reintervention (surgical or catheter based) that occurred after the index surgery. Planned staged procedures were not considered reinterventions.
Follow-up: All follow-up examinations were measured from the date of the index procedure. All index procedures occurred at the tertiary care centre; however, initial palliation for the BiVC/ BiVR group may have occurred at an outside institution.
Outcomes: The outcomes of interest included (i) mortality/ transplant, (ii) any reintervention, (iii) surgical reintervention and (iv) catheter reintervention.
Predictors: The primary predictor was the type of surgery (SV, BiV or BiVC/BiVR). When comparing the outcomes with the type of surgical procedure, the following variables were considered: age, gender, presence of Down syndrome, presence of heterotaxy, presence of pulmonary vein disease, presence of additional cardiac anomalies (e.g. double-outlet right ventricle, transposition of the great arteries, superior inferior venticles, or total anomalous pulmonary venous return) and dominant ventricle (right versus left).
Statistical analysis
Patient and procedural characteristics were summarized as frequencies and percentages for categorical variables and medians and ranges for continuous variables. Because we were interested in time to event and length of follow-up, which differed substantially across patients, we used the Cox regression, where relationships between risk factors and outcomes are estimated as hazard ratios, irrespective of whether data are prospective or retrospective. The times to death/transplant and to the first postdischarge reintervention were estimated using the Kaplan-Meier method with the BiV group as the reference. Cox proportional hazard models were used to evaluate the relationship between the repair groups and the outcomes of death/transplant and unplanned reinterventions after the index surgery, adjusting for clinically relevant predictor variables, and presented as hazard ratios with 95% confidence intervals. Analyses comparing the 3 management strategies were adjusted for all patient characteristics in which the groups differed (Table 1) . Therefore, the hazard ratios for SV and BiVR/BiVC versus BiV can be interpreted as the relative risk between these groups, with all other factors remaining constant. Additional subgroup analysis was performed comparing the BiV to the BiVC group. Statistical analyses were performed with IBM SPSS Statistics for Windows, version 23. (Fig. 1) . The median length of followup was 35 months (range 1-192 months). The baseline characteristics and the outcomes of the 3 groups are shown in Table 1 .
RESULTS
There
On univariable analysis, age, trisomy 21, heterotaxy, pulmonary vein disease and complex cardiac anomalies were significant. The findings from the multivariable analysis for death/ transplant and reinterventions are shown in Tables 2-5. Table 6 outlines the unplanned reinterventions by groups. On multivariable modelling, the SV and BiVC groups had a higher risk for catheter-based reinterventions. There were no patients in the BiVC group who required takedown to a palliated pathway. The BiV repair group needed fewer catheter-based reinterventions compared with the SV and BiVC/BiVR groups. The BiVC/BiVR group had a survival benefit similar to that of the primary BiV repair group when compared to the SV group. Kaplan-Meier ( Fig. 2) estimates demonstrated a survival advantage in the BiV and BiVC/BiVR groups (log-rank P = 0.005).
On adjusted subgroup analysis, the BiVC group was remarkably similar to the BiV repair group, except for catheter-based interventions (hazard ratio 3.1; 95% confidence interval 1.3-7.3; P < 0.01). The log-rank P-value for the Kaplan-Meier estimates between the 2 groups for death/transplant was 0.5; for any reintervention 0.2; for surgical reintervention 0.7 and for catheterbased reintervention 0.002.
The numbers were too small to make a meaningful statistical comparison between right (R) dominant and left (L) dominant CASVSD in the BiVC group; therefore, descriptive statistics are provided. In our cohort, for patients with R dominant CASVSD who underwent BiVC based on preoperative 2D echocardiogram, the median indexed left ventricular (LV) end-diastolic volume [LVEDVi = LVEDV/body surface area (BSA) 1.3 ] was 32 ml/m 2 [interquartile range (IQR) = 21 ml/m 2 , 40 ml/m 2 ]. The corresponding echocardiographic z-scores for LVEDV were as follows: median: -3.15 IQR: -3.81 to -2.44. On magnetic resonance imaging (MRI) in this cohort, the LVEDVi was 36 ml/m 2 (IQR = 25-47 ml/m 2 ). There are no z-scores currently available for LVEDV from MRI scans. On echocardiograms, the common AVV override to the right was 67% (IQR: 60-69%) and on MRI scans, it was 75% (IQR 67-82%). Rates of reintervention were as follows: R dominant CASVSD: 18 of 29 (62%) vs L dominant CASVSD: 10 of 21 (48%). Similarly, mortality rates following BiVC were as follows: R dominant CASVSD: 2/29 (7%) vs L dominant CASVSD: 2 of 21 (9.5%).
If one looks more closely at the BiVC/BiVR group, there were 7 deaths, with 4 in the BiVC group and 3 in the BiVR group. On comparing the characteristics of those who survived compared with those who died in the BiVC group, the survivors had larger LVEDVi with a median of 32 ml/m 2 in the R dominant CASVSD with a median LVEDV z-score of -3.1 vs 19 ml/m 2 and -3.2 in the non-survivors. In the L dominant group, severe right ventricular hypoplasia was present in 38% of survivors vs Associated cardiac anomalies include double-outlet right ventricle, congenitally corrected and dextro-transposition of the great arteries and superior-inferior ventricles. The index surgery for (i) single ventricle palliation was the Norwood/pulmonary artery banding/BTS/BDG, whichever was first; (ii) primary BiV repair was BiV repair; (iii) staged BiV repair was BiV repair; (iv) BiV recruitment was the first recruitment procedure and (v) BiV conversion was the surgical procedure where SV circulation was converted to BiV circulation. SV: single ventricle; BiV: biventricular; BDG: bidirectional Glenn; BTS: Blalock-Taussig shunt.
a There were 8 patients with balanced atrioventricular septal defect who underwent SV to BiV conversion, all of them had heterotaxy. These patients were deemed unbalanced at the outside institution that performed the SV palliation based either on the size of the ventricle or the abnormality of the atrioventricular valve. b P-values were derived using the v 2 test for patient characteristics and the log-rank test for outcomes. Significant values appear in bold.
c Some patients had more than 1 reintervention. Only unplanned reinterventions after the index procedure were included. The BDG and Fontan procedures were not included in the reintervention for the SV group.
100% of non-survivors. When we looked at the BiV recruitment group, we found no difference between survivors and nonsurvivors in the R dominant CASVSD with a median LVEDVi of 28 ml/m 2 . On follow-up imaging, patients who had BiVC for R dominant CASVSD demonstrated a significant increase in LVEDVi (Supplementary Material, Fig. S1 ). On comparing LVEDVi and LVEDV z-scores, the median LVEDVi on echocardiographic scans increased from 32 ml/m 2 to 72 ml/m 2 . The LVEDV z-score increased from a median of -3.15 to +0.42. The LVEDVi on MRI increased from a median of 31 to 61 ml/m 2 . These changes were Of the 26 patients with heterotaxy in the BiVC group, 15 (58%) required reintervention, and there were 2 (8%) deaths, both in the reintervention group. Of the 6 patients with heterotaxy in the BiV recruit group, 5 (83%) required reintervention, with 1 (17%) death in the reintervention group. Of the 57 patients with heterotaxy in the SV group, 33 (58%) required reintervention. There were 13 (23%) deaths, of which 9 (69%) were in the reintervention group. Of the 12 heterotaxy patients in the BiV repair group, 7 (58%) required reintervention. There were 4 deaths, with 3 (75%) of the deaths occurring in the reintervention group. The majority (75%) of deaths in the heterotaxy group had some form of unplanned reintervention, likely representing greater disease complexity (Supplementary Material, Fig. S2 ).
DISCUSSION
This study represents our experience with the management of unbalanced CASVSDs. Our institutional preference is primary BiV repair. If this is not feasible, every attempt is made towards BiVR or BiVC. We have been able to demonstrate a survival benefit in the BiV repair and the BiVC/BiVR groups compared with those receiving SV palliation, albeit at the cost of more reinterventions, particularly catheter-based interventions in the BiVC/BiVR group compared with the primary BiV repair group. Based on ventricular dominance, in the BiVC/BiVR group, the common reinterventions to anticipate for the R dominant CASVSD are AVV reintervention, followed by reintervention on the LV outflow tract. For L dominant CASVSD, the likely reinterventions would be AVV reinterventions, followed by right ventricular outflow tract reinterventions. The goal of achieving a BiV circulation is to mitigate the short-and long-term adverse effects of non-pulsatile flow in the pulmonary circulation associated with SV palliation. Not surprisingly, SV palliation had the highest mortality/transplant rate and the highest rate of reinterventions among the 3 groups.
BiVC for unbalanced CASVSDs is still an evolving field with limited data. Creation of an adequate inflow, particularly during infancy, may be the single most important factor that promotes growth of the AVV and ventricle [6, 7, [9] [10] [11] [12] [13] . Foker et al. demonstrated that increasing atrioventricular flow could induce growth not only of the AVV but also of the associated ventricle [12] . A staged approach is often required to reach the appropriate end-point. The authors reported an 87% mid-term survival rate, although about a quarter of the patients did require subsequent intervention on the AVV [13] .
Children with Down syndrome are a high-risk group in whom establishing a BiV circulation primarily or by recruitment/conversion from SV physiology may be beneficial [8, 14] . As demonstrated in this study, only 4 (8%) of the 51 patients with trisomy 21 underwent SV palliation, 29 (57%) underwent primary BiV repair and 18 (35%) underwent BiVR or BiVC. Recently, a greater proportion of children with heterotaxy are being managed with BiV repair/recruitment or conversion at our institution (Supplementary Material, Fig. S2 ). As depicted in Table 1 , the highest distribution of heterotaxy (69.5%) was in the SV group with a mortality/transplant rate of 32%, followed by the BiVC recruitment group (51% heterotaxy) with a mortality rate of 11%. We believe that SV circulation is tolerated poorly not only in patients with trisomy 21 but also in those with heterotaxy. It has been our institutional practice to attempt a BiV repair for both of these groups if feasible.
Deciding how to manage this complex group of patients requires an assessment of clinical, imaging and haemodynamic data [15] [16] [17] [18] [19] [20] [21] [22] . Ventricular volumes determined by 3D echocardiograms and MRI scans may guide therapy with the ability to recruit ventricles with volumes as low as 15-30 ml/m 2 [6, 7, 17] . The modified AVV index, the right ventricle:LV inflow angle, and the LV inflow index [15, 16, [20] [21] [22] may also aid in deciding between primary BiV repair versus staged BiVC/BiVR. At our centre, the decision to convert from prior SV palliation for R dominant CASVSD was based on the indexed LVEDV. Thus, for the R dominant CASVSD, we used a cut-off indexed LVEDV of 25-30 ml/m 2 . In addition, the LV should be near apex forming and the left AVV mural leaflet should be adequate. In R dominant CASVSD, an LVEDVi of less than 20 ml/m 2 has been associated with non-survival at our centre, although the numbers of deaths in this group are small. For the L dominant CASVSD with a small RV, the decision is based on the ability to create sufficient right AVV inflow by appropriate septation of the common AVV and release of tethered chordae where applicable and ensuring adequate right ventricular cavity by aggressive muscle bundle resection and addition of an infundibular or transannular patch/ right ventricle-pulmonary artery conduit where appropriate. The ultimate decision is often made in the operating room, where establishment of adequate inflow and ventricular rehabilitation can be carried out based on the patient's anatomy.
Limitations
This study has some limitations. It is a retrospective study, with inherent issues of missing data, particularly in the SV group where ascertainment of reinterventions was not always possible, particularly in those followed outside our centre. The BiVC and BiVR strategies are new; thus, duration of follow-up is shorter in this group. The number of patients in each subgroup is small. As numbers accrue, we plan to perform additional subgroup analyses of those with borderline imbalance and longitudinal analysis of changes in LV dimensions, volumes and function.
CONCLUSION
BiVC or BiVR from an SV pathway can be achieved with reasonably low mortality and morbidity rates, given the complexity of the diagnosis, and may provide a survival advantage. This strategy may be particularly important in high-risk groups such as patients with trisomy 21 and heterotaxy who tolerate SV palliation poorly. Early establishment of adequate inflow and outflow may be key in allowing ventricular growth and normalization of the compliance of the hypoplastic ventricular chamber with the resulting ability to sustain a BiV circulation.
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